β-Sitosterol, as a core active component of various formulations, has been reported to enhance SOD activity in diabetic kidney disease rats and restore SOD expression in liver injury models, demonstrating its critical antioxidant role through modulation of oxidative stress pathways (Devaraj et al., 2020; Han et al., 2025). The gene discussed is SOD1; the disease is diabetic kidney disease.